Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Treatment of moderate to severe pediatric asthma: Omalizumab and potential future use of monoclonal antibodies.

Literature DB >> 27371967

Treatment of moderate to severe pediatric asthma: Omalizumab and potential future use of monoclonal antibodies.

Lakiea S Wright¹, Wanda Phipatanakul².

Abstract

Entities: Chemical Disease Gene Species

Mesh：

Substances：

Year: 2016 PMID： 27371967 PMCID： PMC4931721 DOI： 10.1016/j.anai.2016.03.022

Source DB: PubMed Journal: Ann Allergy Asthma Immunol ISSN： 1081-1206 Impact factor: 6.347

× No keyword cloud information.

25 in total

1. The role of cockroach allergy and exposure to cockroach allergen in causing morbidity among inner-city children with asthma.

Authors: D L Rosenstreich; P Eggleston; M Kattan; D Baker; R G Slavin; P Gergen; H Mitchell; K McNiff-Mortimer; H Lynn; D Ownby; F Malveaux
Journal: N Engl J Med Date: 1997-05-08 Impact factor: 91.245

2. Lebrikizumab treatment in adults with asthma.

Authors: Jonathan Corren; Robert F Lemanske; Nicola A Hanania; Phillip E Korenblat; Merdad V Parsey; Joseph R Arron; Jeffrey M Harris; Heleen Scheerens; Lawren C Wu; Zheng Su; Sofia Mosesova; Mark D Eisner; Sean P Bohen; John G Matthews
Journal: N Engl J Med Date: 2011-08-03 Impact factor: 91.245

3. The effect of an anti-IgE monoclonal antibody on the early- and late-phase responses to allergen inhalation in asthmatic subjects.

Authors: J V Fahy; H E Fleming; H H Wong; J T Liu; J Q Su; J Reimann; R B Fick; H A Boushey
Journal: Am J Respir Crit Care Med Date: 1997-06 Impact factor: 21.405

4. Trends in asthma prevalence, health care use, and mortality in the United States, 2001-2010.

Authors: Lara J Akinbami; Jeanne E Moorman; Cathy Bailey; Hatice S Zahran; Michele King; Carol A Johnson; Xiang Liu
Journal: NCHS Data Brief Date: 2012-05

Review 5. Environmental remediation in the treatment of allergy and asthma: latest updates.

Authors: Lakiea S Wright; Wanda Phipatanakul
Journal: Curr Allergy Asthma Rep Date: 2014-03 Impact factor: 4.806

Review 6. Evolving Concepts of Asthma.

Authors: Marc Gauthier; Anuradha Ray; Sally E Wenzel
Journal: Am J Respir Crit Care Med Date: 2015-09-15 Impact factor: 21.405

Treatment of moderate to severe pediatric asthma: Omalizumab and potential future use of monoclonal antibodies.

1. The role of cockroach allergy and exposure to cockroach allergen in causing morbidity among inner-city children with asthma.

2. Lebrikizumab treatment in adults with asthma.

3. The effect of an anti-IgE monoclonal antibody on the early- and late-phase responses to allergen inhalation in asthmatic subjects.

4. Trends in asthma prevalence, health care use, and mortality in the United States, 2001-2010.

Review 5. Environmental remediation in the treatment of allergy and asthma: latest updates.

Review 6. Evolving Concepts of Asthma.

7. Effect of SCH55700, a humanized anti-human interleukin-5 antibody, in severe persistent asthma: a pilot study.

8. Mouse allergen is the major allergen of public health relevance in Baltimore City.

9. Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial.

10. A phase II placebo-controlled study of tralokinumab in moderate-to-severe asthma.

Review 1. Taming Asthma in School-Aged Children: A Comprehensive Review.